切割到核心:瘤骨接口中的蛋白酶和转移性进展
Ridhi Bhola1, Reegan Sturgeon1, Rakesh K Singh1
1Department of Pathology, Microbiology, and Immunology, The University of Nebraska Medical Center, 985845 Nebraska Medical Center, Omaha, NE 68198-5845, United States of America.
Biochimica et biophysica acta. Reviews on cancer
|March 1, 2026
概括
矩阵金属蛋白酶 (MMPs) 和甲素是乳腺癌和前列腺癌转移中的关键蛋白酶. 准这些酶为骨转移提供了一个有希望的治疗策略.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 蛋白酶,包括矩阵金属蛋白酶 (MMP) 和甲素,是癌症进展的关键调节剂.
- 这些酶在乳腺癌和前列腺癌的发展和转移中起着重要作用.
研究的目的:
- 阐明MMPs和cathepsins在癌症进展和转移中的多方面的作用.
- 突出其作为治疗点的潜力,特别是在骨转移中.
主要方法:
- 对癌症中蛋白酶功能的现有文献进行审查和分析.
- 专注于MMPs和cathepsins在细胞外矩阵重塑和瘤-瘤相互作用中的酶活性.
主要成果:
- MMPs和cathepsins降解和重塑细胞外基质,通过表皮转移到介质酶转变促进瘤的侵入性.
- 这些蛋白酶参与了多个转移性步骤:静脉注入,免疫逃避和静脉外流.
- 它们通过激活骨质细胞和释放生长因子来驱动骨质溶解活性,从而在骨转移中产生骨质破坏的循环.
结论:
- 乳腺癌和前列腺癌中MMP和cathepsins是瘤进展和转移的关键驱动因素.
- 它们在骨转移中的作用很重要,包括骨质细胞激活和骨破坏.
- 向MMPs和cathepsins为治疗骨转移性乳腺癌和前列腺癌提供了一个有希望的治疗途径.
相关概念视频
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Tumor Progression
7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K
Role of Matrix Metalloproteases in Degradation of ECM
3.5K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.5K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
The Proteasome
1.9K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.9K
The Proteasome
10.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.4K


